North America Transfection Reagents and Equipment Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Transfection Reagents and Equipment Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Transfection Reagents and Equipment Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Transfection Reagents and Equipment Market Regional Analysis

6.2 North America Transfection Reagents and Equipment Market Revenue 2020-2030 (US$ Million)

6.3 North America Transfection Reagents and Equipment Market Forecast Analysis

7. North America Transfection Reagents and Equipment Market Analysis – by Product

7.1 Reagents and Instruments

7.1.1 Overview
7.1.2 Reagents and Instruments: North America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Transfection Reagents and Equipment Market Analysis – by Method

8.1 Viral Methods

8.1.1 Overview
8.1.2 Viral Methods: North America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Non-Viral Methods

8.2.1 Overview
8.2.2 Non-Viral Methods: North America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Hybrid Methods

8.3.1 Overview
8.3.2 Hybrid Methods: North America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Transfection Reagents and Equipment Market Analysis – by End User

9.1 Academics & Research Institutes and Pharmaceutical & Biotechnology Companies

9.1.1 Overview
9.1.2 Academics & Research Institutes and Pharmaceutical & Biotechnology Companies : North America Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Transfection Reagents and Equipment Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Transfection Reagents and Equipment Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 North America Transfection Reagents and Equipment Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 US: North America Transfection Reagents and Equipment Market Breakdown, by Product
10.2.1.1.2 US: North America Transfection Reagents and Equipment Market Breakdown, by Method
10.2.1.1.3 US: North America Transfection Reagents and Equipment Market Breakdown, by End User

10.2.1.2 Canada: North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 Canada: North America Transfection Reagents and Equipment Market Breakdown, by Product
10.2.1.2.2 Canada: North America Transfection Reagents and Equipment Market Breakdown, by Method
10.2.1.2.3 Canada: North America Transfection Reagents and Equipment Market Breakdown, by End User

10.2.1.3 Mexico : North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 Mexico : North America Transfection Reagents and Equipment Market Breakdown, by Product
10.2.1.3.2 Mexico : North America Transfection Reagents and Equipment Market Breakdown, by Method
10.2.1.3.3 Mexico : North America Transfection Reagents and Equipment Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Promega Corp

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 F. Hoffmann-La Roche Ltd

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Bio-Rad Laboratories Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Mirus Bio LLC

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 QIAGEN NV

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Merck KGaA

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Lonza Group AG

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 MaxCyte Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Polyplus-Transfection SA

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Transfection Reagents and Equipment Market

Analysis - by Product (Reagents and Instruments), Method (Viral Methods, Non-Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)